Evidence map›Paper›PMID 34654584›Full record

Trial reportJournal of substance abuse treatment2022

Volunteer Recovery Support for Adolescents: Using propensity score based methods to understand dosage effects within a randomized controlled trial.

Mark D Godley, Lora L Passetti, Brooke D Hunter, Beth Ann Griffin

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of substance abuse treatment, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Mark D GodleyChestnut Health Systems, 448 Wylie Drive, Normal, IL 61761, USA. Electronic address: mgodley@chestnut.org.
Lora L PassettiChestnut Health Systems, 448 Wylie Drive, Normal, IL 61761, USA. Electronic address: lpassetti@chestnut.org.
Brooke D HunterChestnut Health Systems, 448 Wylie Drive, Normal, IL 61761, USA. Electronic address: bdhunter@chestnut.org.
Beth Ann GriffinRAND Corporation, 1200 South Hayes Street, Arlington, VA 22202, USA. Electronic address: bethg@rand.org.
Chestnut Health Systems · USRAND Corporation · US

Funding

Improving Causal Inference Tools for Addiction ResearchersR01DA045049 · NIDA · RAND CORPORATION · PI GRIFFIN, BETH ANN, MCCAFFREY, DANIEL F · 2018 to 2020
$2.4M
Volunteer Telephone Continuing Care for Adolescents with AOD Use DisordersR01AA021118 · NIAAA · CHESTNUT HEALTH SYSTEMS, INC. · PI GODLEY, MARK D · 2013 to 2017
$2.2M
NIAAA NIH HHS R01 AA021118NIDA NIH HHS R01 DA045049
6 · The paper itself

Abstract

backgroundIn a recently published randomized controlled trial (RCT) of Volunteer Recovery Support for Adolescents (VRSA), a secondary finding indicated that better adherence to planned VRSA telephone session frequency resulted in significantly higher remission rates relative to lower session adherence. However, interpretation of this dose-response relationship may have been confounded by participant characteristics such as baseline levels of substance use and mental health problems.

methodsThe present study used statistical methods designed to approximate RCTs when comparing more than two nonequivalent groups that include an assessment of the potential impact of omitted variables. Classification and Regression Tree (CRT) analysis was used to establish the cut-point between high (H) and low (L) VRSA dosage groups. Because we were interested in generalizing to youth with poor attendance, the L-VRSA group served as the reference group. Balancing weights for H-VRSA and a services as usual (SAU) control group were calculated to ensure similarity of baseline pretreatment characteristics to the reference group, and sensitivity of findings to unobserved confounding variables was assessed.

resultsFindings suggested that superior remission rates at the end of the intervention phase were the result of high adherence to planned VRSA session frequency. Recommendations to achieve high VRSA participation among a larger segment of youth and to test whether longer VRSA duration improves the stability of recovery outcomes are provided.

conclusionFew published dose-response studies have adequately controlled for selection confounds from both observed and unobserved confounding. As such, the present study aims to both assess the impact of different dosage levels of VRSA and provide a template for how to apply state-of-the-art statistical methods designed to approximate randomized controlled trials to such studies.

Indexed as

Substance-Related DisordersAdolescentHumansPatient CompliancePropensity ScoreTelephoneVolunteersAdolescentCausal inferenceOmitted variablePropensity scoresRecovery supportSubstance use disorder

Identifiers

PMID34654584
PMCPMC8671322
OpenAlexW3204999702

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.